Hyderabad, June 26 -- Hyderabad based vaccine manufacturer Bharat Biotech International Limited (BBIL) and global pharma major GSK have jointly pledged support to Gavi, the Vaccine Alliance, in accelerating the rollout of the world's first malaria vaccine, RTS,S.

As part of their commitment, Bharat Biotech announced that the price of the RTS,S vaccine will be reduced by more than half to under $5 per dose by 2028. This major price drop is made possible through increased production capacity, improved manufacturing processes, and reduced profit margins, the Hyderabad-based vaccine manufacturer said in a statement.

The pricing announcement is part of both companies' pledges for Gavi's next funding cycle, known as Gavi 6.0 (2026-2030).

Glo...